Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02177695
Title S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Southwest Oncology Group

urinary bladder cancer


Cisplatin + Gemcitabine

Aldoxorubicin + Cisplatin + Filgrastim + Methotrexate + Vinblastine

Age Groups: adult
Covered Countries USA

No variant requirements are available.